Cheng-Wei Chou
Overview
Explore the profile of Cheng-Wei Chou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
383
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li C, Bai L, Wei Y, Lee H, Yang R, Yao J, et al.
bioRxiv
. 2024 Nov;
PMID: 39484589
As a double-stranded RNA-editing enzyme and an interferon-stimulated gene, double-stranded RNA-specific adenosine deaminase (ADAR1) suppresses interferon signaling and contributes to immunotherapy resistance. Suppression of ADAR1 overcomes immunotherapy resistance in preclinical...
2.
Tseng K, Hsu C, Shih Y, Lin H, Li Y, Teng C, et al.
Ther Adv Med Oncol
. 2024 May;
16:17588359241247019.
PMID: 38716478
Background: The limited efficacy of chemotherapy in improving survival in pancreatic ductal adenocarcinoma (PDAC) necessitates the exploration of novel strategies to overcome treatment resistance. Objectives: This study aimed to investigate...
3.
Shih Y, Lin H, Liao P, Chou C, Lin C, Hsu C, et al.
BMC Cancer
. 2023 Aug;
23(1):770.
PMID: 37596599
Background: Adjuvant chemotherapy is recommended as the standard treatment for patients with stage II/III resected gastric cancer. However, it is unclear whether older patients also benefit from an adjuvant chemotherapy...
4.
Lai C, Lin C, Su Y, Shih Y, Wang C, Teng C, et al.
Cancer Med
. 2022 Nov;
12(6):6802-6810.
PMID: 36426417
Background: Hepatitis B virus (HBV) affects the occurrence and survival outcome of various malignant disorders. The study aimed to evaluate the survival outcome of head and neck squamous cell cancer...
5.
Liao P, Cheng S, Chou C, Lin H, Lin C, Chen T, et al.
Clin Med Insights Oncol
. 2022 Sep;
16:11795549221123617.
PMID: 36134036
Background: Palliative chemotherapy is the preferred standard of care for patients with metastatic gastric cancer (mGC). It remains uncertain whether older patients with mGC would benefit from palliative chemotherapy. This...
6.
Chen J, Chou C
Medicina (Kaunas)
. 2022 May;
58(5).
PMID: 35630056
: Mesenchymal chondrosarcoma is a rare but aggressive subtype of sarcoma. The majority of involvement locates in the axial skeleton. Treatment modalities include radical surgery, local radiotherapy, and systemic chemotherapy....
7.
Lin C, Chen T, Shih Y, Chou C, Hsu C, Li P, et al.
J Int Med Res
. 2022 Feb;
50(2):3000605221078466.
PMID: 35187981
Objective: The outcomes of patients with acute myeloid leukemia (AML) who relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) are poor. However, the risk factors for relapse in this context...
8.
Liao P, Teng C, Chou C
Vaccines (Basel)
. 2021 Dec;
9(12).
PMID: 34960232
We present a case of immune thrombocytopenia (ITP) induced by the chimpanzee adenovirus-vectored vaccine, without evidence of thrombosis, eight days after vaccine administration. The thrombocytopenia condition improved after administering steroid...
9.
Chou C, Hsieh Y, Ku S, Shen W, Anuraga G, Ta H, et al.
Biomedicines
. 2021 Nov;
9(11).
PMID: 34829830
Pancreatic ductal adenocarcinoma (PDAC) is a highly fatal malignancy with poor survival outcomes. In addition, oxysterol-binding protein-like (OSBPL) family members are reported to be involved in lipid binding and transport...
10.
Lin C, Shih Y, Chen T, Chou C, Hsu C, Teng C
J Clin Med
. 2021 Nov;
10(21).
PMID: 34768633
To investigate the potential treatment evolution and outcome improvement, we retrospectively compared clinical characteristics, therapeutic strategies, treatment responses, and overall survival (OS) in patients diagnosed and treated with lymphoma-associated HLH...